Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.

The British journal of radiology - 1 Jul 2016

Lovinfosse Pierre, Koopmansch Benjamin, Lambert Frederic, Jodogne Sébastien, Kustermans Gaelle, Hatt Mathieu, Visvikis Dimitris, Seidel Laurence, Polus Marc, Albert Adelin, Delvenne Philippe, Hustinx Roland

Abstract excerpt

OBJECTIVE: Treating metastatic colorectal cancer with anti-EGFR monoclonal antibodies is recommended only for patients whose tumour does not harbour mutations of KRAS or NRAS. The aim of this study was to investigate the biology of rectal cancers and specifically to evaluate the relationship between fluorine-18 fludeoxyglucose ((18)F-FDG) positron emission tomography (PET) intensity and heterogeneity parameters...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Genes, ras

Share to Positron Emission Tomography Computed Tomography

Share to Radiopharmaceuticals

Share to Rectal Neoplasms

Share to Rectum

Source

Open in PubMed Open full text

Identifiers

PMID: 27146067
DOI: 10.1259/bjr.20160212
PMCID: PMC5257332

Genes

KRAS
NRAS
BRAF
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.PMID 27146067Read ↗

Characterizing MRI features of rectal cancers with different KRAS status.Semantic proximity Read ↗

Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal CancerSemantic proximity Read ↗

Metabolic Imaging Phenotype Using Radiomics of [18F]FDG PET/CT Associated with Genetic Alterations of Colorectal Cancer.Semantic proximity Read ↗

Pretreatment 18F-FDG PET/CT Imaging Predicts the KRAS/NRAS/BRAF Gene Mutational Status in Colorectal CancerSemantic proximity Read ↗

Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer.Semantic proximity Read ↗

Comprehensive Overview of Molecular, Imaging, and Therapeutic Challenges in Rectal Mucinous AdenocarcinomaSemantic proximity Read ↗

Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level.Semantic proximity Read ↗

Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?Semantic proximity Read ↗

Diagnostic Accuracy of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer: A Systematic Review and Meta-analysisSemantic proximity Read ↗

Magnetic resonance imaging based radiomics for predicting pathogenetic features and survival in rectal cancer.Semantic proximity Read ↗

Genetic Alterations in Colorectal Cancer Have Different Patterns on 18F-FDG PET/CT.Semantic proximity Read ↗

Radiomics-Derived Data by Contrast Enhanced Magnetic Resonance in RAS Mutations Detection in Colorectal Liver MetastasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.